{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T00:11:50Z","timestamp":1773274310833,"version":"3.50.1"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81971404"],"award-info":[{"award-number":["81971404"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2018YFC1004603"],"award-info":[{"award-number":["2018YFC1004603"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Placenta"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.placenta.2022.10.014","type":"journal-article","created":{"date-parts":[[2022,11,3]],"date-time":"2022-11-03T03:35:27Z","timestamp":1667446527000},"page":"17-24","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Downregulation of PDCD4 by deSUMOylation associates with the progression of gestational trophoblastic disease"],"prefix":"10.1016","volume":"130","author":[{"given":"Ya-Xin","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ling","family":"Cui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei-Bin","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin John","family":"Quinn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ramkumar","family":"Menon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiu-Ru","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9548-1702","authenticated-orcid":false,"given":"Hui-Juan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.placenta.2022.10.014_bib1","series-title":"The WHO Classification of Tumours Editorial Board , Female Genital Tumours","year":"2022"},{"key":"10.1016\/j.placenta.2022.10.014_bib2","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.placenta.2021.02.013","article-title":"Gestational trophoblastic neoplasia: novelties and challenges","volume":"116","author":"Silva","year":"2021","journal-title":"Placenta"},{"issue":"Suppl 2","key":"10.1016\/j.placenta.2022.10.014_bib3","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1002\/ijgo.12615","article-title":"Update on the diagnosis and management of gestational trophoblastic disease","volume":"143","author":"Ngan","year":"2018","journal-title":"Int. J. Gynaecol. Obstet."},{"issue":"24","key":"10.1016\/j.placenta.2022.10.014_bib4","doi-asserted-by":"crossref","first-page":"14037","DOI":"10.1073\/pnas.96.24.14037","article-title":"Differentially expressed protein Pdcd4 inhibits tumor promoter-induced neoplastic transformation","volume":"96","author":"Cmarik","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"11","key":"10.1016\/j.placenta.2022.10.014_bib5","doi-asserted-by":"crossref","first-page":"8095","DOI":"10.4049\/jimmunol.177.11.8095","article-title":"Translational regulation of autoimmune inflammation and lymphoma genesis by programmed cell death 4","volume":"177","author":"Hilliard","year":"2006","journal-title":"J. Immunol."},{"issue":"5","key":"10.1016\/j.placenta.2022.10.014_bib6","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1002\/path.1378","article-title":"Loss of PDCD4 expression in human lung cancer correlates with tumour progression and prognosis","volume":"200","author":"Chen","year":"2003","journal-title":"J. Pathol."},{"key":"10.1016\/j.placenta.2022.10.014_bib7","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/1476-4598-8-70","article-title":"Loss of Programmed cell death 4 (Pdcd4) associates with the progression of ovarian cancer","volume":"8","author":"Wei","year":"2009","journal-title":"Mol. Cancer"},{"issue":"8","key":"10.1016\/j.placenta.2022.10.014_bib8","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1111\/j.1349-7006.2009.01210.x","article-title":"PDCD4 inhibits the malignant phenotype of ovarian cancer cells","volume":"100","author":"Wei","year":"2009","journal-title":"Cancer Sci."},{"issue":"9","key":"10.1016\/j.placenta.2022.10.014_bib9","first-page":"4676","article-title":"Inhibition of cell migration and invasion and promotion of cell apoptosis by overexpression of programmed cell death 4 (PDCD4) in cervical cancer Siha cells","volume":"11","author":"Zeng","year":"2018","journal-title":"Int. J. Clin. Exp. Pathol."},{"issue":"31","key":"10.1016\/j.placenta.2022.10.014_bib10","doi-asserted-by":"crossref","first-page":"4550","DOI":"10.1038\/sj.onc.1210234","article-title":"Tumor suppressor Pdcd4 inhibits invasion\/intravasation and regulates urokinase receptor (u-PAR) gene expression via Sp-transcription factors","volume":"26","author":"Leupold","year":"2007","journal-title":"Oncogene"},{"issue":"27","key":"10.1016\/j.placenta.2022.10.014_bib11","doi-asserted-by":"crossref","first-page":"3921","DOI":"10.1038\/onc.2010.158","article-title":"Pdcd4 repression of lysyl oxidase inhibits hypoxia-induced breast cancer cell invasion","volume":"29","author":"Santhanam","year":"2010","journal-title":"Oncogene"},{"issue":"2","key":"10.1016\/j.placenta.2022.10.014_bib12","first-page":"1402","article-title":"Programmed cell death factor 4 enhances the chemosensitivity of colorectal cancer cells to Taxol","volume":"18","author":"Wang","year":"2019","journal-title":"Oncol. Lett."},{"issue":"2","key":"10.1016\/j.placenta.2022.10.014_bib13","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1158\/1535-7163.103.3.2","article-title":"Characterization of programmed cell death 4 in multiple human cancers reveals a novel enhancer of drug sensitivity","volume":"3","author":"Jansen","year":"2004","journal-title":"Mol. Cancer Therapeut."},{"issue":"12","key":"10.1016\/j.placenta.2022.10.014_bib14","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1046\/j.1440-1827.1999.00995.x","article-title":"Novel human PDCD4 (H731) gene expressed in proliferative cells is expressed in the small duct epithelial cells of the breast as revealed by an anti-H731 antibody","volume":"49","author":"Yoshinaga","year":"1999","journal-title":"Pathol. Int."},{"issue":"4","key":"10.1016\/j.placenta.2022.10.014_bib15","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1007\/s00432-011-1140-8","article-title":"PDCD4 expression inversely correlated with miR-21 levels in gastric cancers","volume":"138","author":"Cao","year":"2012","journal-title":"J. Cancer Res. Clin. Oncol."},{"issue":"9","key":"10.1016\/j.placenta.2022.10.014_bib16","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20092304","article-title":"Control mechanisms of the tumor suppressor PDCD4: expression and functions","volume":"20","author":"Matsuhashi","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"3","key":"10.1016\/j.placenta.2022.10.014_bib17","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1042\/BSR20110045","article-title":"Promoter cloning and characterization of the human programmed cell death protein 4 (pdcd4) gene: evidence for ZBP-89 and Sp-binding motifs as essential Pdcd4 regulators","volume":"32","author":"Leupold","year":"2012","journal-title":"Biosci. Rep."},{"issue":"10","key":"10.1016\/j.placenta.2022.10.014_bib18","doi-asserted-by":"crossref","first-page":"4257","DOI":"10.1111\/j.1582-4934.2008.00497.x","article-title":"PDCD4 gene silencing in gliomas is associated with 5'CpG island methylation and unfavourable prognosis","volume":"13","author":"Gao","year":"2009","journal-title":"J. Cell Mol. Med."},{"issue":"2","key":"10.1016\/j.placenta.2022.10.014_bib19","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1097\/IGC.0000000000000861","article-title":"miR-21 is overexpressed in hydatidiform mole tissues and promotes proliferation, migration, and invasion in choriocarcinoma cells","volume":"27","author":"Wang","year":"2017","journal-title":"Int. J. Gynecol. Cancer"},{"issue":"1","key":"10.1016\/j.placenta.2022.10.014_bib20","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1186\/s13046-019-1358-x","article-title":"DTL promotes cancer progression by PDCD4 ubiquitin-dependent degradation","volume":"38","author":"Cui","year":"2019","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"5798","key":"10.1016\/j.placenta.2022.10.014_bib21","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1126\/science.1130276","article-title":"S6K1- and betaTRCP-mediated degradation of PDCD4 promotes protein translation and cell growth","volume":"314","author":"Dorrello","year":"2006","journal-title":"Science"},{"issue":"7","key":"10.1016\/j.placenta.2022.10.014_bib22","doi-asserted-by":"crossref","DOI":"10.1098\/rsob.210050","article-title":"SUMOylation modification-mediated cell death","volume":"11","author":"Sheng","year":"2021","journal-title":"Open Biol."},{"issue":"1","key":"10.1016\/j.placenta.2022.10.014_bib23","doi-asserted-by":"crossref","first-page":"5120","DOI":"10.1038\/s41467-020-18794-x","article-title":"Concepts of extracellular matrix remodelling in tumour progression and metastasis","volume":"11","author":"Winkler","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.placenta.2022.10.014_bib24","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.semcancer.2019.09.004","article-title":"Emerging roles of ECM remodeling processes in cancer","volume":"62","author":"Mohan","year":"2020","journal-title":"Semin. Cancer Biol."},{"issue":"5","key":"10.1016\/j.placenta.2022.10.014_bib25","article-title":"Angiogenin and MMP-2 as potential biomarkers in the differential diagnosis of gestational trophoblastic diseases","volume":"101","author":"Weng","year":"2022","journal-title":"Medicine (Baltim.)"},{"issue":"4","key":"10.1016\/j.placenta.2022.10.014_bib26","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1093\/molehr\/8.4.392","article-title":"Reduced expression of tissue inhibitor of metalloproteinase (TIMP)-2 in gestational trophoblastic diseases","volume":"8","author":"Okamoto","year":"2002","journal-title":"Mol. Hum. Reprod."},{"issue":"10","key":"10.1016\/j.placenta.2022.10.014_bib27","first-page":"1409","article-title":"Overexpression of trophoblastic stem cell transcription factor,forkhead boxD3,contributes to malignancy of human choriocarcinoma JAR cells","volume":"20","author":"Liu","year":"2016","journal-title":"Chin. J. Tissue Eng. Res."},{"issue":"10","key":"10.1016\/j.placenta.2022.10.014_bib28","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/j.placenta.2014.07.012","article-title":"Dysregulated activation of c-Src in gestational trophoblastic disease contributes to its aggressive progression","volume":"35","author":"Wu","year":"2014","journal-title":"Placenta"},{"issue":"11","key":"10.1016\/j.placenta.2022.10.014_bib29","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1021\/acsmedchemlett.0c00353","article-title":"Synthesis and evaluation of ginkgolic acid derivatives as SUMOylation inhibitors","volume":"11","author":"Brackett","year":"2020","journal-title":"ACS Med. Chem. Lett."},{"issue":"2","key":"10.1016\/j.placenta.2022.10.014_bib30","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.lungcan.2008.03.022","article-title":"Pdcd4 protein and mRNA level alterations do not correlate in human lung tumors","volume":"62","author":"Kalinichenko","year":"2008","journal-title":"Lung Cancer"},{"key":"10.1016\/j.placenta.2022.10.014_bib31","first-page":"22","article-title":"The activation of PI3 K\/PKB signaling in pathogenesis of gestational trophoblastic disease","volume":"1","author":"Wang","year":"2015","journal-title":"Prog. Obstet. Gynecol."},{"key":"10.1016\/j.placenta.2022.10.014_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2021.109394","article-title":"Ginkgoic acid impedes gastric cancer cell proliferation, migration and EMT through inhibiting the SUMOylation of IGF-1R","volume":"337","author":"Liu","year":"2021","journal-title":"Chem. Biol. Interact."},{"issue":"20","key":"10.1016\/j.placenta.2022.10.014_bib33","doi-asserted-by":"crossref","DOI":"10.1242\/jcs.234120","article-title":"Inhibiting SUMO1-mediated SUMOylation induces autophagy-mediated cancer cell death and reduces tumour cell invasion via RAC1","volume":"132","author":"Lorente","year":"2019","journal-title":"J. Cell Sci."},{"issue":"24","key":"10.1016\/j.placenta.2022.10.014_bib34","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21249739","article-title":"The roles of matrix metalloproteinases and their inhibitors in human diseases","volume":"21","author":"Cabral-Pacheco","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"17","key":"10.1016\/j.placenta.2022.10.014_bib35","doi-asserted-by":"crossref","first-page":"15164","DOI":"10.18632\/oncotarget.3897","article-title":"MMP3-mediated tumor progression is controlled transcriptionally by a novel IRF8-MMP3 interaction","volume":"6","author":"Banik","year":"2015","journal-title":"Oncotarget"},{"issue":"2","key":"10.1016\/j.placenta.2022.10.014_bib36","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1038\/s41416-018-0136-4","article-title":"High-serum MMP-8 levels are associated with decreased survival and systemic inflammation in colorectal cancer","volume":"119","author":"Sirnio","year":"2018","journal-title":"Br. J. Cancer"},{"issue":"17","key":"10.1016\/j.placenta.2022.10.014_bib37","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1016\/j.ejca.2003.08.011","article-title":"Cytokine-regulated expression of collagenase-2 (MMP-8) is involved in the progression of ovarian cancer","volume":"39","author":"Stadlmann","year":"2003","journal-title":"Eur. J. Cancer"},{"issue":"2","key":"10.1016\/j.placenta.2022.10.014_bib38","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s10549-008-9993-5","article-title":"Programmed cell death 4 inhibits breast cancer cell invasion by increasing tissue inhibitor of metalloproteinases-2 expression","volume":"114","author":"Nieves-Alicea","year":"2009","journal-title":"Breast Cancer Res. Treat."}],"container-title":["Placenta"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0143400422004398?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0143400422004398?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T18:07:36Z","timestamp":1758910056000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0143400422004398"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":38,"alternative-id":["S0143400422004398"],"URL":"https:\/\/doi.org\/10.1016\/j.placenta.2022.10.014","relation":{},"ISSN":["0143-4004"],"issn-type":[{"value":"0143-4004","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Downregulation of PDCD4 by deSUMOylation associates with the progression of gestational trophoblastic disease","name":"articletitle","label":"Article Title"},{"value":"Placenta","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.placenta.2022.10.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}